Victor M. Artahona-Albarran
Barcelona, CT, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Tumor Purity as a Prognostic and Predictive Biomarker of Postoperative Radiation Therapy Outcomes in Stage IIIA-N2 Non-Small Cell Lung Cancer: A Transcriptomic Analysis From the Lung ART Trial.
Journal: International journal of radiation oncology, biology, physics
Published: October 15, 2025
Prognostic Value of Systemic Inflammation and Clinical Variables in Malignant Pleural Mesothelioma: A Real-World Study.
Journal: Archivos de bronconeumologia
Published: June 04, 2025
Frequency of driver oncogenic alterations in NSCLC and estimated indoor radon exposure in Europe (RADON EUROPE study).
Journal: Therapeutic advances in medical oncology
Published: March 07, 2025
Brief Report: Real-World Clinical Utility of Next-Generation Sequencing of Circulating Tumor DNA for Patients With Advanced Lung Squamous Cell Carcinoma (SQUIN).
Journal: Clinical lung cancer
Published: October 05, 2024
Upfront osimertinib and as sequential therapy in patients with EGFR-mutant non-small cell lung cancer (NSCLC): benefit across patients groups in a real-world retrospective cohort-the smile study.
Journal: Translational lung cancer research
Published: September 23, 2024
Association Between Lung Immune Prognostic Index and Durvalumab Consolidation Outcomes in Patients With Locally Advanced Non-Small-Cell Lung Cancer.
Journal: Clinical lung cancer
Published: August 22, 2023
Interpretability of radiomics models is improved when using feature group selection strategies for predicting molecular and clinical targets in clear-cell renal cell carcinoma: insights from the TRACERx Renal study.
Journal: Cancer imaging : the official publication of the International Cancer Imaging Society
Published: January 10, 2023
Second-line treatment outcomes after progression from first-line chemotherapy plus immunotherapy in patients with advanced non-small cell lung cancer.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: December 19, 2022
Biomarkers of response to immunotherapy in early stage non-small cell lung cancer.
Journal: European journal of cancer (Oxford, England : 1990)
Published: December 09, 2022
Molecular Epidemiology and Treatment Patterns of Patients With EGFR Exon 20-Mutant NSCLC in the Precision Oncology Era: The European EXOTIC Registry.
Journal: JTO clinical and research reports
Published: August 07, 2022
Immune-Related Uncommon Adverse Events in Patients with Cancer Treated with Immunotherapy.
Journal: Diagnostics (Basel, Switzerland)
Published: June 30, 2022
Last Updated: 09/26/2026